The hair growth category is experiencing unprecedented growth, driven by increasing consumer awareness of hair thinning, scalp health, and preventive beauty. However, alongside this growth comes a challenge for formulators and brands: separating scientifically credible technologies from ingredients supported primarily by marketing claims.
While many ingredients claim to stimulate hair growth or reduce hair loss, relatively few meet the criteria that formulation scientists, regulatory teams, and R&D professionals should expect from a modern active ingredient.
When assessing any hair growth technology, the discussion should move beyond claims and focus on evidence. The key question is not whether an ingredient is innovative, but whether the innovation is supported by robust science.
Historically, hair care formulations relied heavily on botanical extracts, vitamins, amino acids, and circulation enhancing ingredients. While many of these materials continue to play a role in scalp care, the industry is increasingly moving toward biotechnology derived solutions designed to interact with biological pathways associated with follicle function and hair cycling.
This trend reflects a broader shift occurring across the personal care industry. Rather than relying solely on ingredients with indirect cosmetic benefits, developers are now seeking actives with clearly defined mechanisms of action and measurable performance outcomes.
Growth factors, peptides, stem cell derived technologies, and biomimetic proteins have therefore emerged as areas of interest within both skin and hair care research.
From a formulation and product development perspective, credibility can generally be assessed across five areas:
A credible active should have a scientifically plausible mechanism linked to known processes involved in hair follicle biology.
Hair growth is regulated by complex interactions between signalling proteins, cellular communication pathways, follicular stem cells, inflammatory mediators, and extracellular matrix components. Ingredients that are capable of influencing these pathways in a meaningful way are generally more interesting than those relying purely on cosmetic effects.
The mechanism does not need to be revolutionary, but it should be understandable, reproducible, and supported by experimental evidence.
One of the most significant weaknesses in the hair growth sector is the absence of well-designed human studies.
Many ingredients are supported only by in vitro testing or supplier generated screening data. While these studies can provide useful insights, they do not necessarily predict real world efficacy.
A stronger evidence package includes:
The quality of the study design often tells formulators more than the marketing claims themselves.
Protein based and biotechnology derived ingredients frequently face challenges related to stability.
An active may demonstrate excellent biological activity under laboratory conditions but fail to maintain performance during manufacturing or throughout product shelf life.
This is particularly relevant for growth factors and signalling proteins, which are often sensitive to temperature, oxidation, processing conditions, and formulation environment.
For this reason, delivery technology becomes just as important as the active itself.
Ingredient performance is only meaningful when the manufacturing process delivers consistent output between batches.
One of the advantages of biotechnology platforms is their ability to produce highly controlled materials with reproducible composition. This contrasts with some natural extracts, where seasonal variation and raw material quality can lead to greater variability.
Consistency is particularly important when brands intend to support efficacy claims with testing data.
Hair growth ingredients are attracting increased regulatory attention, particularly when claims move closer to therapeutic territory.
Developers should therefore consider:
These factors are becoming increasingly important as consumers demand greater transparency regarding ingredient sourcing and sustainability.
Core Biogenesis provides an interesting example of how biotechnology is being applied within personal care ingredient development.
The company uses plants as biofactories to produce biomimetic proteins and growth factors rather than relying on conventional extraction methods. Their platform integrates growth factors with naturally derived oleosomes, lipid structures found within oil rich seeds. According to published data, this approach was developed to address key challenges associated with protein stability and delivery.
From a formulation science perspective, this approach is noteworthy because stability remains one of the major obstacles for protein-based actives.
The company reported that oleosome associated growth factors retained more than 92% bioactivity during a 12 week stability program compared with substantially lower retention observed for unprotected proteins.
Whether applied to skin care or future hair care technologies, improving protein stability remains an important area of innovation.
A useful example of evidence generation comes from the independent clinical study conducted by Abich Lifeanalytics on formulations containing Core Biogenesis growth factor technologies.
The study involved 44 volunteers aged between 40 and 65 years and evaluated multiple skin parameters using objective instrumental methods including Antera 3D analysis, Cutometer measurements, TEWL assessment, and clinical grading. Participants applied products twice daily for 60 days.
What makes this study relevant to formulators is not necessarily the specific efficacy outcomes, but the testing methodology itself.
The study incorporated:
These are exactly the types of validation approaches that should be expected when evaluating any advanced active ingredient, including those intended for hair growth applications.
The next generation of hair growth technologies will likely be evaluated less on their novelty and more on the quality of evidence supporting them.
For formulators, the most useful questions remain straightforward:
As biotechnology continues to expand within the personal care industry, ingredient credibility will increasingly depend on rigorous science rather than compelling storytelling.
The future of hair growth innovation is unlikely to be driven by a single breakthrough ingredient. Instead, it will be shaped by technologies that successfully combine biological relevance, manufacturing consistency, formulation practicality, and robust clinical validation. Companies such as Core Biogenesis demonstrate how the industry is moving toward this more evidence driven approach, offering valuable lessons for formulators evaluating the next generation of cosmetic actives.
About OC Consulting
OC Consulting supports beauty and personal care brands with formulation development, ingredient evaluation, claims substantiation, testing strategy, and regulatory guidance.